ODYSSEY Outcomes: Alirocumab Reduces MACE, Non-fatal MI, Ischemic Stroke, and All-Cause Mortality in ACS Patients Dr. Schwartz and Dr. Gibson Discuss By Tarek Nafee, M.D. on March 11, 2018 http://cardiologynownews.org/wp-content/uploads/2018/03/sun_945_schwartz.mp4
Leave a Reply
You must be logged in to post a comment.